https://iwp-2inhibitor.com/low....er-influence-associa
This study included 11 customers whom got bevacizumab before or after radiotherapy (group A) and 30 patients who received mainstream chemoradiotherapy without bevacizumab (group . We excluded the following patients individuals with dual primary cancers; those whose pathologic diagnosis ended up being neither squamous mobile carcinoma nor adenocarcinoma; those who failed to undergo radiotherapy; or those from whom follow-up information could not be gathered. We examined the pro
Like
Comment
Share
